TEVA PHARMACEUTICAL INDUSTRIES LTDTEVABalance sheet

Market cap
$36.7B
P/E ratio
2010/122011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
Cash and cash equivalents 1,2481,0962,8791,0382,2266,9469889631,7821,9752,1772,1982,8343,2273,300
Marketable securities, current 36--------------
Total cash & short-term investments1,2841,0962,8791,0382,2266,9469889631,7821,9752,1772,1982,8343,2273,300
Accounts receivable, net5,4766,2135,5725,3385,4085,3507,5237,1285,8225,6764,5814,5293,6963,4083,059
Inventories3,8665,0125,5025,0534,3713,9664,9544,9244,7314,4224,4033,8183,8334,0213,007
Total current assets12,04214,45316,35513,72014,39618,39816,96115,38213,79413,46413,00512,57312,05112,48512,552
Property, plant and equipment, net4,3575,9476,3156,6356,5356,5448,0737,6736,8686,4366,2965,9825,7395,7504,581
Total non-current assets26,11035,68934,25433,78832,02435,86075,92955,23346,88944,00637,63535,09331,95530,99426,774
Total assets 38,15250,14250,60947,50846,42054,25892,89070,61560,68357,47050,64047,66644,00643,47939,326
Long-term debt, current ---------1,8312,6741,4032,0861,6491,758
Total current liabilities9,69413,84712,88811,96512,28913,00518,51917,92114,32213,67413,16411,02711,46912,24712,796
Total non-current liabilities6,45613,95214,85412,90710,77611,32639,37833,94930,56728,73326,41425,39523,84623,10620,809
Total liabilities 16,15027,79927,74224,87223,06524,33157,89751,87044,88942,40739,57936,42235,31535,35333,606
Common stock and paid-in capital 13,29513,42413,52413,67814,17117,80923,46323,533,000,00027,26627,36827,50027,61827,74527,86427,822
Retained earnings9,32511,28412,34612,53514,43614,85113,607-3,803-5,958-6,956-10,946-10,529-12,882-13,534-15,173
Stockholders' equity22,00222,34322,86722,63623,35529,92734,99318,74515,79415,06311,06111,2448,6918,1265,380
Total debt---------1,8312,6741,4032,0861,6491,758
Net debt----------144497-795-748-1,578-1,542
D/E ratio (%)---------12.224.212.52420.332.7